AURKA Monoclonal antibody 66757-1-Ig proteintech

$149.00
In stock
SKU
66757-1-Ig
Catalog No.SizePrice (USD)
66757-1-IG-20UL20 μL$149.00
66757-1-IG-150UL150 μL$449.00
66757-1-IG-10X150UL1.5 mL (10 x 150 μL vials)$3,592.00
Catalog Number66757-1-Ig
SynonymsAurora A, 1F4B10, AIRK1, ARK-1, AURA
HostMouse
Reactivityhuman, mouse, rat
FormLiquid
FormulationPBS, Azide, Glycerol
ApplicationsWB, IHC, IF/ICC, IP, CoIP, ChIP, ELISA
ApplicationsWB, IHC, IF/ICC, ELISA
Host / IsotypeMouse / IgG3
Tested Applications — Positive WB detected inhuman testis tissue, HeLa cells, NCCIT cells, rat testis tissue, mouse testis tissue
Tested Applications — Positive IHC detected inhuman breast cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Tested Applications — Positive IF/ICC detected inHeLa cells, A431 cells
Recommended Dilutions — Western Blot (WB)WB : 1:1000-1:6000
Recommended Dilutions — Immunohistochemistry (IHC)IHC : 1:300-1:1200
Recommended Dilutions — Immunofluorescence (IF)/ICCIF/ICC : 1:400-1:1600
Positive WB detected inhuman testis tissue, HeLa cells, NCCIT cells, rat testis tissue, mouse testis tissue
Positive IHC detected inhuman breast cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Positive IF/ICC detected inHeLa cells, A431 cells
Western Blot (WB)WB : 1:1000-1:6000
Immunohistochemistry (IHC)IHC : 1:300-1:1200
Immunofluorescence (IF)/ICCIF/ICC : 1:400-1:1600
Tested Reactivityhuman, mouse, rat
Cited Reactivityhuman, mouse
ClassMonoclonal
TypeAntibody
ImmunogenCatNo: Ag20096 Product name: Recombinant human AURKA protein Source: e coli. -derived, PET28a Tag: 6*His Domain: 108-337 aa of BC002499 Sequence: NNPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET Predict reactive species
Full Nameaurora kinase A
Calculated Molecular Weight46 kDa
Observed Molecular Weight46-52 kDa
GenBank Accession NumberBC002499
Gene SymbolAURKA
Gene ID (NCBI)6790
RRIDAB_2882103
ConjugateUnconjugated
Purification MethodProtein A purification
UNIPROT IDO14965
Storage BufferPBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20 o C storage. 20ul sizes contain 0.1% BSA.
IF protocol for AURKA antibody 66757-1-IgDownload protocol
IHC protocol for AURKA antibody 66757-1-IgDownload protocol
WB protocol for AURKA antibody 66757-1-IgDownload protocol
humanWB Biochim Biophys Acta Mol Basis Dis Blocking AURKA with MK-5108 attenuates renal fibrosis in chronic kidney disease. Authors - Mingzhu Jiang View Article
Sarah-Eve (Verified Customer) (06-02-2023)Works well, WB dilution 1:2000 Applications: Western Blot Cell Tissue Type: Human pulmonary artery smooth muscle cells
Citations38
DilutionsWB : 1:1000-1:6000 IHC : 1:300-1:1200 IF/ICC : 1:400-1:1600
IsotypeIgG3
ClonalityMonoclonal
Clone Number1F4B10
ConjugationUnconjugated

AURKA(Aurora kinase A), also named as STK6, STK15 or AIK, belongs to the Ser/Thr protein kinase family. This protein may play a role in cell cycle regulation during anaphase and/or telophase by being involved in microtubule formation and/or stabilization. Some recent evidence revealed that AURKA may also be implicated in tumor development and progression. AURKA is expressed highly in testis and various proliferating cells, migrating as a 46 kDa protein in SDS PAGE.Nuclear staining for AURKA is weak or nonexistent in normal tissue but strong in tumor tissue(PMID:19107951). Protocols Product Specific Protocols IF protocol for AURKA antibody 66757-1-Ig Download protocol IHC protocol for AURKA antibody 66757-1-Ig Download protocol WB protocol for AURKA antibody 66757-1-Ig Download protocol Standard Protocols Click here to view our Standard Protocols

Publications

  1. PUF60/AURKA Axis Contributes to Tumor Progression and Malignant Phenotypes in Bladder Cancer.
    Journal: Front Oncol | Authors: Qian Long | Species: human | Application: WB
  2. Proteomics and phosphoproteomics of chordoma biopsies reveal alterations in multiple pathways and aberrant kinases activities
    Journal: Front Oncol | Authors: Jing Hang KD Validated | Species: human | Application: WB
  3. Integrated Analysis of Transcriptome Data Revealed AURKA and KIF20A as Critical Genes in Medulloblastoma Progression.
    Journal: Front Oncol | Authors: Bo Liang | Species: human | Application: IHC
  4. Palmatine induces G2/M phase arrest and mitochondrial-associated pathway apoptosis in colon cancer cells by targeting AURKA.
    Journal: Biochem Pharmacol | Authors: Xiaojiang Liu | Species: human | Application: WB
  5. ARID3A promotes the development of colorectal cancer by upregulating AURKA.
    Journal: Carcinogenesis | Authors: Jing Tang | Species: human | Application: WB
  6. Blocking AURKA with MK-5108 attenuates renal fibrosis in chronic kidney disease.
    Journal: Biochim Biophys Acta Mol Basis Dis | Authors: Mingzhu Jiang | Species: human | Application: WB
  7. Vascular restenosis following paclitaxel-coated balloon therapy is attributable to NLRP3 activation and LIN9 upregulation
    Journal: J Transl Med | Authors: Qinghui Kan | Species: human
  8. The kinesin motor Kif9 regulates centriolar satellite positioning during interphase.
    Journal: Curr Biol | Authors: Juan Jesus Vicente | Species: human | Application: WB,IF
  9. Palmatine induces G2/M phase arrest and mitochondrial-associated pathway apoptosis in colon cancer cells by targeting AURKA.
    Journal: Biochem Pharmacol | Authors: Xiaojiang Liu | Species: human | Application: WB
  10. Bavachinin exerts anti-tumor effects by activating TLR4/STING axis-dependent PANoptosis and synergistically enhances chemosensitivity in endometrial cancer
    Journal: Biochem Pharmacol | Authors: Wan Shu | Species: human | Application: WB
  11. Tabersonine enhances cisplatin sensitivity by modulating Aurora kinase A and suppressing epithelial-mesenchymal transition in triple-negative breast cancer
    Journal: Pharm Biol | Authors: Xi Chen | Species: human | Application: WB
  12. AURKA activates FOXO3a to form a positive feedback loop in the proliferation and migration of keloid fibroblasts
    Journal: Adv Wound Care (New Rochelle) | Authors: Xi Chu | Species: human | Application: WB,IF,CoIP,ChIP
  13. The Effect of Circumscribed Exposure to the Pan-Aurora Kinase Inhibitor VX-680 on Proliferating Euploid Cells
    Journal: Int J Mol Sci | Authors: Xumei Liu | Species: human | Application: WB
  14. Blocking AURKA with MK-5108 attenuates renal fibrosis in chronic kidney disease.
    Journal: Biochim Biophys Acta Mol Basis Dis | Authors: Mingzhu Jiang | Species: human | Application: WB
  15. TAK-901, a novel EPHA2 inhibitor as a therapeutic strategy against prostate cancer
    Journal: Cell Signal | Authors: Shanhui Liu | Species: human | Application: WB
  16. The DNA-PKcs-primary cilia axis maintains ionizing radiation-induced senescence in tumor cells.
    Journal: Acta Biochim Biophys Sin (Shanghai) | Authors: Xiuzhu Liu | Species: human | Application: WB
  17. The Role of TRPC6 in Renal Ischemia/Reperfusion and Cellular Hypoxia/Reoxygenation Injuries.
    Journal: Front Mol Biosci | Authors: Xin Hou | Species: mouse | Application: WB
  18. Inflammation Inhibits HECTD1-Mediated AURKA Ubiquitination to Cause Extracellular Matrix Degradation in Osteoarthritis via Enhancing Cap-Dependent mRNA Translation of ADAMTS12
    Journal: FASEB J | Authors: Duo Xia | Application: IF
  19. AURKA enhances the glycolysis and development of ovarian endometriosis through ERβ
    Journal: Endocrinology | Authors: Yujun Sun | Species: mouse,human | Application: WB,IHC
  20. ARID3A promotes the development of colorectal cancer by upregulating AURKA.
    Journal: Carcinogenesis | Authors: Jing Tang | Species: human | Application: WB
  21. AURKA regulates HBV-induced hepatic stellate cell inflammation and liver fibrosis by modulating K48-linked ubiquitination and proteasomal degradation of TLR3.
    Journal: J Bioenerg Biomembr | Authors: Hongjie Wu
  22. Proliferation-associated 2G4 P48 is stabilized by malignant T-cell amplified sequence 1 and promotes the proliferation of head and neck squamous cell carcinoma
    Journal: J Dent Sci | Authors: Legang Sun | Species: human | Application: WB
  23. Adiponectin Inhibits AURKA to Suppress Inflammation in TNF-α-induced Keratinocytes and Attenuates Psoriatic Dermatitis in Mice.
    Journal: Immun Inflamm Dis | Authors: Lingling Zhang | Species: mouse | Application: WB
  24. The aberrantly activated AURKB supports and complements the function of AURKA in CALR mutated cells through regulating the cell growth and differentiation
    Journal: Exp Cell Res | Authors: Xueting Hu | Species: human | Application: WB
  25. Bisphenol A-sulfate conjugate disrupts AURKA transcription and cell cycle in BeWo cytotrophoblasts.
    Journal: Mol Cell Endocrinol | Authors: Jumpei Fujiki | Species: human | Application: WB
  26. Integrated Analysis of Transcriptome Data Revealed AURKA and KIF20A as Critical Genes in Medulloblastoma Progression.
    Journal: Front Oncol | Authors: Bo Liang | Species: human | Application: IHC
  27. Proteomics and phosphoproteomics of chordoma biopsies reveal alterations in multiple pathways and aberrant kinases activities
    Journal: Front Oncol | Authors: Jing Hang | Species: human | Application: WB
  28. PUF60/AURKA Axis Contributes to Tumor Progression and Malignant Phenotypes in Bladder Cancer.
    Journal: Front Oncol | Authors: Qian Long | Species: human | Application: WB
  29. The N-terminal region of HASPIN regulates phosphorylation of AURKA and meiotic progression in spermatocytes
    Journal: Mol Cell Endocrinol | Authors: Haojie Li | Species: mouse | Application: WB
  30. Resveratrol inhibits bladder cancer proliferation by targeting the AURKA/STAT3 axis: From computational analysis to experimental validation.
    Journal: PLoS One | Authors: Chao Feng | Species: human | Application: WB
  31. Cellular senescence-Related genes define the immune microenvironment and molecular characteristics in severe asthma patients
    Journal: Gene | Authors: Qibin Lin | Species: mouse | Application: WB
  32. TPX2 as a prognostic biomarker and potential therapeutic target for malignant melanoma proliferation and metastasis.
    Journal: Exp Ther Med | Authors: Fuqi Li | Species: human | Application: WB
  33. AURKA Enhances Antitumor Immunity by Activating CD4+ T Cell Proliferation in Colorectal Cancer
    Journal: Cancer Invest | Authors: Yidong Xu | Species: human | Application: IHC
  34. Aurora kinase A promotes epithelial‑mesenchymal transition by regulating P130 and P107 molecules in thyroid cancer cells
    Journal: Exp Ther Med | Authors: Liyun Yang | Species: human | Application: WB,IF
  35. WGCNA and machine learning identify AURKA, CDK1, and other hub genes associated with immune infiltration as therapeutic targets in GIST: An integrative bioinformatics analysis.
    Journal: Medicine (Baltimore) | Authors: Ailing Chen | Species: human | Application: WB
  36. Integrating multiple key molecules in uveal melanoma to uncover metastatic and immune microenvironment-related gene signatures.
    Journal: Int J Ophthalmol | Authors: Yi-Ming Guo | Species: human | Application: WB
  37. A Cuproptosis-Glycolysis Signature Predicts Prognosis and Highlights AURKA as a Therapeutic Target in ccRCC.
    Journal: Hum Mutat | Authors: Chang-yu Ma | Species: mouse,human | Application: WB
  38. The kinesin motor Kif9 regulates centriolar satellite positioning and mitotic progression
    Journal: bioRxiv | Authors: Juan Jesus Vicente | Species: human | Application: IF
  39. DOT1L-mediated H3K79me3 of ITCH promotes AURKA ubiquitination to suppress ECM degradation in osteoarthritis.
    Journal: Mol Genet Genomics | Authors: Duo Xia
  40. Deciphering early molecular responses to aristolactam I associated with hepatocellular carcinoma: Computational prediction of a core gene signature and identification of transcription-translation uncoupling under acute aristolactam I exposure.
    Journal: Ecotoxicol Environ Saf | Authors: Qing Peng
  41. LncTRDMT1-5 promotes chromosomal instability through MSRB3-mediated cell cycle and DNA damage in breast cancer.
    Journal: Front Oncol | Authors: Qi Chen

Reviews

Write Your Own Review
You're reviewing:AURKA Monoclonal antibody 66757-1-Ig proteintech
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.